Interestingly, CD44+/CD90+ cells [243] and CD44+/CD133+ [125] cells isolated from human HCC present a more aggressive phenotype than either CD133 positive or CD90 positive cells alone. This evidence concerns the gene THY1 and hepatocellular carcinoma.